Previous studies of brown adipocytes identified an increased breakdown of phosphoinositides after selective az-adrenergic-receptor activation. The present paper reports that this response, elicited with phenylephrine in the presence of propranolol and measured as the accumulation of [3H]inositol phosphates, is accompanied by increased release of [3H]arachidonic acid from cells prelabelled with [3H]arachidonic acid. Differences between stimulated arachidonic acid release and formation of inositol phosphates included a requirement for extracellular Ca21 for stimulated release of arachidonic acid but not for the formation of inositol phosphates and the preferential inhibition of inositol phosphate formation by phorbol 12-myristate 13-acetate. The release of arachidonic acid in response to phenylephrine was associated with an accumulation ,of [3Hlarachidonic acid-labelled diacylglycerol, and this response was not dependent on extracellular Ca2' but was partially prevented by treatment with the phorbol ester. The release of arachidonic acid was also stimulated by melittin, which increases the activity of phospholipase A2, by ionophore A23187, by lipolytic stimulation with forskolin and by exogenous phospholipase C. The arachidonic acid response to phospholipase C was completely blocked by RHC 80267, an inhibitor of diacylglycerol lipase, but this inhibitor had no effect on release stimulated with melittin or A23187 and inhibited phenylephrine-stimulated release by only 40 %. The arachidonate response to forskolin was additive with the responses to either phenylephrine or exogenous phospholipase C. These data indicate that brown adipocytes are capable of releasing arachidonic acid from neutral lipids via triacylglycerol lipolysis, and from phospholipids via phospholipase A2 or by the sequential activities of phospholipase C and diacylglycerol lipase. Our findings also suggest that the action of phenylephrine to promote the liberation of arachidonic acid utilizes both of these reactions.
INTRODUCTION
Brown adipose tissue is a unique organ having the sole physiological function of thermogenic heat production. Thermogenesis is made possible by the presence of a unique regulated proton-conductance pathway found only in mitochondria of brown-fat cells (Nicholls & Locke, 1984) . When open, this pathway allows the re-entry of protons into the mitochondrial matrix, by-passing ATP synthase and uncoupling electron transport from phosphorylation of ADP (Nicholls & Locke, 1984) . Mitochondrial respiration therefore proceeds at an accelerated rate, producing heat but not ATP. The most important physiological regulation of thermogenesis is by catecholamines released from sympathetic nerve endings (Nicholls & Locke, 1984; Bukowiecki, 1984) . Brown adipocytes possess al-and ,f-adrenergic receptors, and the selective activation of either receptor subtype elicits increased thermogenesis Mohell et al., 1983; Bukowiecki, 1984; Ma & Foster, 1984; Horwitz & Hamilton, 1984) .
The /1-adrenergic pathway has been investigated extensively and appears to result from the heightened availability of non-esterified fatty acids within the adipocyte as triacylglycerol hydrolysis is promoted by the cyclic-AMP-dependent activation of lipolysis (Nicholls & Locke, 1984;  Bukowiecki, 1984) .
In contrast, understanding of the mechanisms underlying a-adrenergic activation is more rudimentary. A previous study from our laboratory (Schimmel et al., 1986) reported findings of az-receptor-promoted breakdown of phosphoinositides and a concomitant accumulation of phosphatidic acid in brown-fat-cells labelled by incubation with [32P]P,, and Nanburg & Putney (1986) subsequently identified formation of inositol phosphates in adipocytes stimulated with noradrenaline. The production of arachidonic acid frequently accompanies accelerated phosphoinositide turnover (Irvine, 1982) . The release of free arachidonic acid results from the activity of a phospholipase A2 enzyme or the sequential activities of phospholipase C and diacylglycerol lipase, and the fraction of arachidonate released from either pathway appears to vary widely among different cell types (Hong & Deykin, 1981; Litosch et al., 1982; Lapetina, 1983; Dixon & Hokin, 1984; Burch et al., 1986; Slivka & Insel, 1987; Ho & Klein, 1987) . Arachidonic acid mobilization, along with the formation of prostaglandin E2 and prostaglandin 12, has been reported in white adipocytes in response to noradrenaline, angiotensin, vasopressin and bradykinin (Dalton & Hope, 1974 ; Axelrod & Levine, 1981; Axelrod et al., 1985) , but the contribution of phospholipids as the source of the arachidonic acid released in these cells has been difficult to establish because of the presence of a Vol. 253
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Abbreviations used: PMA, phorbol 12-myristate 13-acetate; InsP, InsP2 and InsP3, inositol mono-, bis-and tris-phosphate. large triacylglycerol store, which can incorporate and liberate radiolabelled arachidonic acid. This problem was obviated by Lewis et al. (1979) , who demonstrated mobilization of arachidonic acid in fat-cell ghosts, which are devoid of most of their triacylglycerol. In this system, release of arachidonic acid could be accounted for by the hydrolysis of membrane phospholipids.
Brown adipocytes contain much less triacylglycerol than do white fat-cells and may be a more useful adipocyte system for investigations into regulation of arachidonic acid and prostaglandin production. Because of previously reported data (Schimmel et al., 1986; Nanburg & Putney, 1986) (Levine & Moskowitz, 1979; Dixon & Hokin, 1984; Slivka & Insel, 1987; Ho & Klein, 1987) , the present experiments were undertaken to determine if production of arachidonic acid accompanied formation of inositol phosphates in brown adipocytes. Our study sought to determine if a-adrenergic activation of arachidonic acid production accompanied activation of phospholipase C and to identify the reactions responsible for release of free arachidonic acid.
MATERIALS AND METHODS Preparation of brown adipocytes
Male hamsters weighing 60-80 g were purchased from Charles River, Lakeview, NJ, U.S.A., and housed in a climate-regulated vivarium for at least 1 week before use. The animals were anaesthetized by intraperitoneal injection of sodium pentobarbital, and the interscapular and cervical brown-fat depots were excised. The white adipose and connective tissues were removed, and the brown fat was minced with scissors for 5 min. Adipocytes were prepared by digestion with crude bacterial collagenase (2.0 mg/ml) for 12 min in the presence of soya-bean trypsin inhibitor (0.33 mg/ml) and 200 nMadenosine. Adenosine was present in the buffers used for tissue digestion and cell incubations; its addition appeared to provide for more uniform cell responses and less adipocyte lysis during preparation, observations reported previously for white-adipocyte preparations (Honnor et al., 1985) . The buffer used contained (in mM) 1 5 NaCl, 1.0 CaCl2, 15 NaHCO3, 4.6 KCI, 1.4 MgSO4 and 30 Hepes adjusted to pH 7.4 after addition of bovine serum albumin (40 mg/ml). Glucose (10 mM), fructose (10 mM) and pyruvate (1.0 mM) were present during digestion of the tissue and for all other incubations except for the incubation monitoring release of [3H]arachidonic acid. After collagenase treatment, the digested tissue was filtered through nylon mesh and the adipocytes were washed with buffer of identical composition.
Analysis of inositol phosphates
For measurement of inositol phosphates, phospholipids were labelled during a cell incubation with 20 /LM- [2-3H] inositol for 2-3 h. In a typical experiment, brown adipocytes from two hamsters (total of 5 x 106-9 x 106 adipocytes) were incubated in 3.0 ml of buffer containing 30 ,uCi of [3H]inositol/ml in a 50 ml conical tube placed on a rocker platform in an incubator at 37 'C. After incubation, the cells were washed and resuspended in fresh buffer of identical composition except for the addition of 10 mM-LiCl. A cell sample was taken at this time for estimation ofcell number with a haemocytometer after staining of the cells with Acridine Orange. The cells were then re-incubated in 1.0 ml portions (containing 0.5 x l06l-.0 x 106 cells) for periods of time indicated in the text. Drug or control solutions were added as specified in the Figure legends . In all experiments, phenylephrine was used as the a-adrenergic agonist, and propranolol was present at 1.0 ,UM to block the /Jadrenergic receptors. The incubations were terminated by addition of cold trichloroacetic acid (final concn. 10 %, w/v). After centrifugation (400 g for 5 min) and removal of the trichloroacetic acid by sequential extractions with 5 vol. of water-saturated diethyl ether, the aqueous phases were applied to columns containing 350 mg of anion-exchange resin AG 1-X8 (formate form, 100-200 mesh). The inositol phosphates were eluted as described by Berridge (1983 [3H]Arachidonic acid was eluted by addition of chloroform/light petroleum (1:1, v/v) exactly as described by Powell (1982 Neutral lipids and phospholipids were extracted from the filters or from the trichloroacetic acid precipitates into chloroform as described by Schimmel et al. (1986) . Phospholipids were resolved by one-dimensional t.l.c. on oxalate-impregnated silica-gel 60 high-performance plates (Merck, Darmstadt, Germany) as described by Schimmel et al. (1986) . Lysophosphatidylcholine was determined by two-dimensional chromatography on silica-gel 60 plates, with chloroform/methanol/ acetic acid/water (25:15 :4: 1, by vol.) in the first dimension and chloroform/methanol/conc. NH3/water (140:60:1:8, by vol.) in the second dimension (Billah & Lapetina, 1982) . Neutral lipids were resolved in one dimension on silica-gel 60 plates (Merck) with the solvent system benzene/diethyl ether/ethyl acetate/ acetic acid (400: 50: 50: 1, by vol.) (Calderon et al., 1979) . With this solvent system, triacylglycerol moves with RF 0.80, diacylglycerols with RF 0.58-0.62, monoacylglycerol with RF 0.15 and unesterified arachidonic acid with RF 0.30. Neutral lipids were detected by I2 staining, and their identity was determined by comparison with authentic standards. Phospholipids were detected by exposure of the plates to a molybdate solution (3 g of ammonium molybdate in 50 ml of water, 5 ml of 6 M-HCI and 13 ml of 70 % HC104) applied as an aerosol spray, followed by heating to 100°C for 10 min and by autoradiography in those experiments involving labelling with 32P. Phospholipid standards were co-migrated to allow identification of the sample lipids. Chemicals Unless stated otherwise, chemicals and materials were purchased from standard sources. The bovine serum albumin (fraction V) was from Boehringer-Mannheim; collagenase (type I) was from Cooper Biomedical; soyabean trypsin inhibitor, arachidonic acid, ionophore A23 187, phorbol 1 2-myristate 13-acetate (PMA), phospholipase C (type IX, from Clostridium perfringens), melittin, phenylephrine, insulin and isoprenaline (isoproterenol) were from Sigma; forskolin was from Calbiochem-Behring; propranolol was from Ayerst; myo-[3H]inositol was from American Radiolabelled Chemical; [3H]arachidonic acid was from New England Nuclear; prazosin was a gift from Pfizer; RHC 80267 { 1 ,6-di [-O-(carbamoyl) cyclohexanone oxime]hexane} was a gift from Revlon.
RESULTS
Our first experiment sought to measure inositol phosphate production in brown adipocytes after stimulation with the az-adrenergic-receptor agonist phenylephrine. After addition of phenylephrine (in the presence of propranolol), the amounts of InsP, InsP2 and InsP3 increased by small, yet quite consistent, amounts (Fig. 1) . The percentage increases in each inositol phosphate were similar, but differences were apparent in their time courses. The accumulation of InsP3 reached a peak 30-60 s after addition of phenylephrine and then decreased during the remainder of the incubation. The accumulation of InsP, however, appeared to proceed for the entire period of incubation, although the largest increase was evident during the first I min after addition of phenylephrine. Basal inositol phosphate production was measured at each time point and was not found to increase during the course of this incubation. That the effect of phenylephrine on accumulation of inositol phosphates is mediated by ax-adrenergic receptors is Period of incubation (min) Fig. 2(b) Table 3 .
Incorporation of [3H]arachidonic acid into phospholipids
was greatest for phosphatidylcholine, with incorporation into phosphatidylethanolamine and phosphatidylinositides being slightly less. 3H radioactivity in phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-bisphosphate amounted to 10 % of the radioactivity present in phosphatidylinositol, and the radiolabelling of these three lipids is combined for presentation in Table 3 . 3H radioactivity was also present in phosphatidic acid, but this accounted for less than 1.0 % of the total label. The distribution of 3H radioactivity among the neutral lipids and phospholipids did not change significantly during incubation of the adipocytes for 10 min. When phenylephrine was added, 3H radioactivity recovered in diacylglycerol and in phosphatidic acid both increased.
[3H]Arachidonic acid radioactivity present in phosphatidylcholine, phosphatidylethanolamine and phosphatidylinositol also tended to increase after addition of phenylephrine, but the percentage increases in these lipids were less than 15 %. Forskolin and phospholipase C
7676+866
Phenylephrine and phospholipase C 5672+495 in response to phospholipase C, and in this instance RHC 80267 was without effect (Fig. 4) (Seamon & Daly, 1981) . Forskolin increased the release of [3H]arachidonic acid (Table 4) and this effect was completely blocked by RHC 80267 (results not shown). When phenylephrine or phospholipase C was present along with forskolin, a greater release of [3H]arachidonic acid was observed that represented a summation of the effects of forskolin and those of the other stimuli (Table 4 ). The incorporation of [3H]arachidonic acid into diacylglycerol did not change after exposure to forskolin (Table 5) , but the stimulatory effect of phenylephrine was still evident in the presence of forskolin. Phospholipase C caused [3H]diacylglycerol to increase by nearly 2-fold, and this effect was also evident in forskolin-stimulated cells.
We next attempted to determine if a-receptorgenerated production of [3H]arachidonic acid could occur in the absence of phospholipase C activation. To answer this question, we took advantage of our finding that phenylephrine stimulation of inositol phosphate accumulation is blocked by treatment with PMA (Fig.  2) . When adipocytes were treated with PMA for 10 min before addition of phenylephrine, a protocol found to block stimulation of inositol phosphate production, the stimulation of [3H]arachidonic acid release was only slightly decreased (Fig. 5) . A small inhibitory effect of PMA was evident after the first 1 min of incubation, but not after 10 min of incubation. When accumulation of
[3H]diacylglycerol was measured (Table 6 ), the stimulatory effect of phenylephrine was partially prevented by treatment with PMA. By itself, PMA had no effect on Because the activation of phospholipase A2 in other systems is dependent on the presence of Ca2" (Billah et al., 1980; Craven & DeRubertis, 1983) , we examined the consequence of removal of extracellular Ca2" on phenylephrine stimulation of [3H]arachidonic acid release. Addition of EGTA, which had no effect on phenylephrine-stimulated production of inositol phosphates, dramatically inhibited phenylephrine-stimulated arachidonic acid release (Fig. 5) , but did not interfere with formation of diacylglycerol ( or A23187 stimulation (Table 7) . This effect of phenylephrine was not observed in the absence of extracellular Ca2", but was present in cells treated with PMA.
However, since diacylglycerol appeared to increase after stimulation of adipocytes with phenylephrine, and since exposure to PMA did cause a small inhibition of phenylephrine-stimulated [3H]arachidonic acid release, we investigated the possible contribution of diacylglycerol lipase to phenylephrine-stimulated release of [3H]arachidonic acid. For this purpose, the effects of RHC 80267 on phenylephrine-stimulated release were determined. When RHC 80267 was present, phenylephrine-stimulated release of [3H]arachidonic acid was decreased by approx. 400 (Fig. 6) 
DISCUSSION
Previous studies on the mechanisms of a,-receptor action in brown fat-cells have identified increased breakdown of 32P-labelled phosphoinositides (Schimmel et al., 1986) , increased accumulation of inositol phosphates (Nanburg & Putney, 1986) and increased efflux of Ca2" from cells prelabelled with 45Ca2" (Connolly et al., 1984) after the selective activation of these receptors. Our present observations demonstrate the presence of an additional component of the a-adrenergic transduction system, namely the liberation of arachidonic acid. These responses may be mediated by a common pool of al-adrenergic receptors, although findings of pharmacologically distinct subtypes of al receptors on smooth-muscle cells, both of which are capable of increasing cell Ca2l (Han et al., 1987) , suggest that additional studies may be needed to characterize the cxreceptor population and their associated actions on brown fat-cells.
-The cellular mechanisms of phenylephrine stimulation of arachidonic acid release in brown fat-cells appear to involve both a direct deacylation of phospholipids with phospholipase A2 and the sequential activities of phospholipase C followed by diacylglycerol lipase. The salient finding consistent with a role of diacylglycerol lipase in phenylephrine action is the partial inhibition of stimulated [3H]arachidonic acid release by RHC 80267, an inhibitor of diacylglycerol lipases (Sutherland & Amin, 1982) . Finding accumulation of [3H]diacylglycerol in response to phenylephrine is consonant with a role of diacylglycerol as a precursor of arachidonic acid release from fat-cells, but, as discussed below, the precursors of this diacylglycerol are not certain. Finding an effect of RHC 80267 on arachidonic acid release from fat-cells differs from FRTL5 thyroid cells (Burch et al., 1986 ) and the pineal gland (Ho & Klein, 1987) , which also respond to al-adrenergic stimulation with release of arachidonic acid, but RHC 80267 in either system is without effect. However, in other cells, principally platelets (Bell et al., 1979) , but also exocrine pancreas (Dixon & Hokin, 1984) and fibrosarcoma cells (Bell et al., 1980) , persuasive evidence has been presented for arachidonic acid release from the deacylation of diacylglycerol generated by a phosphoinositide-specific phospholipase C.
The apparent role of diacylglycerol and diacylglycerol lipase in liberation of arachidonic acid esterified in phospholipids raises the question of whether diacylglycerol derived from phospholipid hydrolysis equilibrates with diacylglycerol arising from lipolysis. At least two observations suggest not. We find that arachidonic acid release inTresponse to phospholipase C or phenylephrine is simply additive with the response to a maximally effective concentration of forskolin. If 
